These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 23183047)

  • 1. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
    Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
    J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB.
    Finlay DK
    Biochem Soc Trans; 2013 Apr; 41(2):681-6. PubMed ID: 23514176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways.
    Kim JS; Sklarz T; Banks LB; Gohil M; Waickman AT; Skuli N; Krock BL; Luo CT; Hu W; Pollizzi KN; Li MO; Rathmell JC; Birnbaum MJ; Powell JD; Jordan MS; Koretzky GA
    Nat Immunol; 2013 Jun; 14(6):611-8. PubMed ID: 23644504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.
    Rao RR; Li Q; Gubbels Bupp MR; Shrikant PA
    Immunity; 2012 Mar; 36(3):374-87. PubMed ID: 22425248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
    D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
    Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
    Zhu Y; Pereira RO; O'Neill BT; Riehle C; Ilkun O; Wende AR; Rawlings TA; Zhang YC; Zhang Q; Klip A; Shiojima I; Walsh K; Abel ED
    Mol Endocrinol; 2013 Jan; 27(1):172-84. PubMed ID: 23204326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8
    Wißfeld J; Hering M; Ten Bosch N; Cui G
    Eur J Immunol; 2024 Jul; 54(7):e2350825. PubMed ID: 38650034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs.
    Shrestha S; Yang K; Wei J; Karmaus PW; Neale G; Chi H
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14858-63. PubMed ID: 25271321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.
    Macintyre AN; Finlay D; Preston G; Sinclair LV; Waugh CM; Tamas P; Feijoo C; Okkenhaug K; Cantrell DA
    Immunity; 2011 Feb; 34(2):224-36. PubMed ID: 21295499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression.
    Das F; Ghosh-Choudhury N; Venkatesan B; Kasinath BS; Ghosh Choudhury G
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F291-F307. PubMed ID: 28424212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxp3 and Toll-like receptor signaling balance T
    Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
    Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation.
    Pollizzi KN; Sun IH; Patel CH; Lo YC; Oh MH; Waickman AT; Tam AJ; Blosser RL; Wen J; Delgoffe GM; Powell JD
    Nat Immunol; 2016 Jun; 17(6):704-11. PubMed ID: 27064374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.
    Miyazaki M; Miyazaki K; Chen S; Chandra V; Wagatsuma K; Agata Y; Rodewald HR; Saito R; Chang AN; Varki N; Kawamoto H; Murre C
    Genes Dev; 2015 Feb; 29(4):409-25. PubMed ID: 25691468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha/Sima.
    Dekanty A; Lavista-Llanos S; Irisarri M; Oldham S; Wappner P
    J Cell Sci; 2005 Dec; 118(Pt 23):5431-41. PubMed ID: 16278294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundances.
    Chen X; Zhu Y; Wang Z; Zhu H; Pan Q; Su S; Dong Y; Li L; Zhang H; Wu L; Lou X; Liu S
    J Proteomics; 2016 Mar; 136():13-24. PubMed ID: 26844761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.